期刊文献+

三种方法检测乙型肝炎YMDD变异的比较研究及临床结果分析 被引量:5

Compurative studies on detection of YMDD mutation in hepatitis B virus by three methods and their clinical results
下载PDF
导出
摘要 目的对检测乙型肝炎病毒(HBV)YMDD变异的3种方法进行灵敏度和特异性比较,并结合患者治疗前HBV DNA载量、丙氨酸氨基转移酶(ALT)水平免疫标志物和YMDD变异后HBV DNA载量等临床信息进行结果分析。方法分别以荧光定量PCR(FQ-PCR)、通用模板信号扩增PCR(UT-PCR)和聚合酶链反应微板核酸杂交-酶联免疫吸附法(PCRmnh-ELISA),对拉米夫定治疗过程中血清出现HBV DNA由阴转阳的52例慢性乙型肝炎患者,进行HBV YMDD变异检测,比较3种方法的敏感性,并对3种方法检测结果不一致的标本进行测序,比较他们的特异性。结果FQ-PCR、UT-PCR和PCRmnh-ELISA对YMDD变异的检出率分别为:53.85%、48.08%、73.07%,FQ-PCR和UT-PCR均与PCRmnh-ELISA差异有统计学意义(P<0.05),FQ-PCR与UT-PCR差异无统计学意义(P>0.1)。检测结果不一致的17例标本进行了测序,FQ-PCR、UT-PCR、PCRmnh-ELISA与检测结果的符合率分别为94.1%、70.6%、29.4%,3者之间差异有统计学意义(P<0.05)。结论3种方法比较,FQ-PCR检测HBV YMDD变异具有较高的灵敏性和特异性,并能同时检测出野生株和变异的混合感染,与测序结果相符,是诊断HBV YMDD变异较好的方法。 Objective To compare the sensitivity and specificity of three methods used to detect YMDD mutation in hepatitis B virus(HBV) , and to analyse the detection results combined with HBV DNA, alanine aminotransferase (ALT) levels,serum markers vefote and after treatment. Methods The sensitivity and specificity of fluorescence quantitative polymerase chain reaction ( FQ-PCR ) and signal universal template polymerase chain reaction (UT-PCR) were com- pared with those of polymerase chain reaction microplate hybridization enzyme-linked immunosorbent assay ( PCRmnh- ELISA) through detection of HBV YMDD mutation in 52 serums from chronic hepatitis B patients rceiving lamivudine monotherapy at the time of viral breakthrough. The inconsistent samples detected by three methods were sequenced. Resuits The rates of HBV YMDD mutation detected by FQ-PCR,UT-PCR and PCRmnh-ELISA were 53.85% ,48.08% and 73. 07% , respectively. There were significant differences between FQ-PCR and PCRmnh-ELISA, UT-PCR and PCRmnh-ELISA (P 〈0.05 ). However,there was not significant difference between FQ-PCR and UT-PCR (P 〉 0. 1 ). The rates of consistency with sequencing in 17 samples were 94.1% by FQ-PCR,70.6% by UT-PCR and 29.4% by PCRmnh-ELISA, respectively, and there were significant differeces among them ( P 〈 0.05 ). Conclusions FQ-PCR is a very good approach for detect ion of HBV YMDD mutations due to the higher sensitivity and specificity,and for the detection of coinfection of wild type and YMDD mutations.
出处 《检验医学》 CAS 北大核心 2009年第3期173-176,共4页 Laboratory Medicine
关键词 乙型肝炎病毒 YMDD变异 FQ—PCR UT—PCR PCRmnh—ELISA Hepatitis B YMDD mutation Fluorescence quantitative polymerase chain reaction Signal universal tem- plate polymerase chain reaction Polymerase chain reaction microplate hybridization-enzyme-linked immunosorbent assay
  • 相关文献

参考文献4

二级参考文献34

  • 1[1]Maddrey WC.Hepatitis B-an important public health issue.Clin Lab 2001; 47:51-55
  • 2[2]Lai CL,Ratziu V,Yuen MF,Poynard T.Viral hepatitis B.Lancet 2003; 362:2089-2094
  • 3[3]Manigold T,Rehermann B.Chronic hepatitis B and hepatocarcinogenesis:does prevention of "collateral damage"bring the cure? Hepatology 2003; 37:707-710
  • 4[4]Lai CL,Chien RN,Leung NW,Chang TT,Guan R,Tai DI,Ng KY,Wu PC,Dent JC,Barber J,Stephenson SL,Gray DF.A one-year trial of lamivudine for chronic hepatitis B.Asia Hepatitis Lamivudine Study Group.N Engl JMed 1998; 339:61-68
  • 5[5]Leung NW,Lai CL,Chang TT,Guan R,Lee CM,Ng KY,Lim SG,Wu PC,Dent JC,Edmundson S,Condreay LD,Chien RN.Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates:results after 3 years of therapy.Hepatology 2001; 33:1527-1532
  • 6[6]Yuen MF,Lai CL.Treatment of chronic hepatitis B.Lancet Infect Dis 2001; 1:232-242
  • 7[7]Hu KQ.A Practical Approach to Management of Chronic Hepatitis B.Int J Med Sci 2005; 2:17-23
  • 8[8]Allen MI,Deslauriers M,Andrews CW,Tipples GA,Walters KA,Tyrrell DL,Brown N,Condreay LD.Identification and characterization of mutations in hepatitis B virus resistant to lamivudine.Lamivudine Clinical Investigation Group.Hepatology 1998; 27:1670-1677
  • 9[9]Gunthard HF,Frost SD,Leigh-Brown AJ,Ignacio CC,Kee K,Perelson AS,Spina CA,Havlir DV,Hezareh M,Looney DJ,Richman DD,Wong JK.Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy.J Virol 1999; 73:9404-9412
  • 10[10]Jardi R,Buti M,Rodriguez-Frias F,Cotrina M,Costa X,Pascual C,Esteban R,Guardia J.Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants.J Virol Methods 1999; 83:181-187

共引文献44

同被引文献39

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部